India’s healthcare and life sciences sector has surpassed its Covid-era fundraising peak, with inflows crossing Rs 62,432 crore, says Equirus. Strong market performance, soaring ECM activity in pharma, and larger M&A deals are driving the surge, with FY26 fundraising already exceeding Rs 72,440 crore.India’s healthcare and life sciences sector has surpassed its Covid-era fundraising peak, with inflows crossing Rs 62,432 crore, says Equirus. Strong market performance, soaring ECM activity in pharma, and larger M&A deals are driving the surge, with FY26 fundraising already exceeding Rs 72,440 crore
​India’s healthcare and life sciences sector has surpassed its Covid-era fundraising peak, with inflows crossing Rs 62,432 crore, says Equirus. Strong market performance, soaring ECM activity in pharma, and larger M&A deals are driving the surge, with FY26 fundraising already exceeding Rs 72,440 crore.India’s healthcare and life sciences sector has surpassed its Covid-era fundraising peak, with inflows crossing Rs 62,432 crore, says Equirus. Strong market performance, soaring ECM activity in pharma, and larger M&A deals are driving the surge, with FY26 fundraising already exceeding Rs 72,440 crore by Soban News (international And National News)
